Advised Vedanta Group to set up a JV with Foxconn, a major Taiwanese multinational for manufacturing semi-conductors in India with capital outlay of over US$ 20 billion.

Advised Viatris inc. in the sale of biosimilar business to Biocon Biologics Ltd, subsidiary of Biocon Ltd for US$ 3.335 billion.

Advised Viatris Inc. and Mylan India in US$ 12 billion acquisition of Upjohn Business from Pfizer inc.

Acted for DIPAM, Government of India in the successful disinvestment of 93.71% of shares of 4 Central Public State Enterprises in Neelanchal Ispat Nigam Ltd. to Tata Steel Long Products Ltd for approx. US$ 1.54 billion (INR 12,100 crores).

Advised Government Of India in Divestment Of 5% Share In IRCTC approx. US$ 331 Million (INR 2726 Crores).

Advised Carlyle Group in the IPO of Medanta Hospital (Global health) issue size of US$ 275 million (INR 2205 crores).